BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31479940)

  • 1. Fluorescent activity-based probe for the selective detection of Factor VII activating protease (FSAP) in human plasma.
    Rut W; Nielsen NV; Czarna J; Poreba M; Kanse SM; Drag M
    Thromb Res; 2019 Oct; 182():124-132. PubMed ID: 31479940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates.
    Kara E; Manna D; Løset GÅ; Schneider EL; Craik CS; Kanse S
    Thromb Haemost; 2017 Aug; 117(9):1750-1760. PubMed ID: 28726978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Factor VII Activating Protease (FSAP) generation assay and its application in studying FSAP in venous thrombosis.
    Etscheid M; Hanschmann KM; Sandset PM; Kanse SM
    Thromb Res; 2022 Dec; 220():24-34. PubMed ID: 36265411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.
    Etscheid M; Muhl L; Pons D; Jukema JW; König H; Kanse SM
    Thromb Res; 2012 Dec; 130(6):935-41. PubMed ID: 22906531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs).
    Grasso S; Neumann A; Lang IM; Etscheid M; von Köckritz-Blickwede M; Kanse SM
    Thromb Res; 2018 Jan; 161():36-42. PubMed ID: 29178989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP).
    Nakazawa F; Kannemeier C; Shibamiya A; Song Y; Tzima E; Schubert U; Koyama T; Niepmann M; Trusheim H; Engelmann B; Preissner KT
    Biochem J; 2005 Feb; 385(Pt 3):831-8. PubMed ID: 15654766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Phage Display-Derived Peptide Interacting with the N-Terminal Region of Factor VII Activating Protease (FSAP) Enables Characterization of Zymogen Activation.
    Berge-Seidl S; Nielsen NV; Rodriguez Alfonso AA; Etscheid M; Kandanur SPS; Haug BE; Stensland M; Thiede B; Karacan M; Preising N; Wiese S; Ständker L; Declerck PJ; Løset GÅ; Kanse SM
    ACS Chem Biol; 2022 Sep; 17(9):2631-2642. PubMed ID: 36070465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Characterization of a New pVII Combinatorial Phage Display Peptide Library for Protease Substrate Mining Using Factor VII Activating Protease (FSAP) as Model.
    Kara E; Nielsen NV; Eggertsdottir B; Thiede B; Kanse SM; Løset GÅ
    Chembiochem; 2020 Jul; 21(13):1875-1884. PubMed ID: 32180321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization.
    Uslu Ö; Herold J; Kanse SM
    Cells; 2019 Nov; 8(11):. PubMed ID: 31698750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a.
    Kanse SM; Gallenmueller A; Zeerleder S; Stephan F; Rannou O; Denk S; Etscheid M; Lochnit G; Krueger M; Huber-Lang M
    J Immunol; 2012 Mar; 188(6):2858-65. PubMed ID: 22308306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular effects of factor VII activating protease (FSAP).
    Byskov K; Etscheid M; Kanse SM
    Thromb Res; 2020 Apr; 188():74-78. PubMed ID: 32087413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men.
    Borkham-Kamphorst E; Zimmermann HW; Gassler N; Bissels U; Bosio A; Tacke F; Weiskirchen R; Kanse SM
    J Hepatol; 2013 Jan; 58(1):104-11. PubMed ID: 22989567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity.
    Olsson M; Stanne TM; Pedersen A; Lorentzen E; Kara E; Martinez-Palacian A; Rønnow Sand NP; Jacobsen AF; Sandset PM; Sidelmann JJ; Engström G; Melander O; Kanse SM; Jern C
    J Thromb Haemost; 2018 Oct; 16(10):2024-2034. PubMed ID: 30070759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tests for the measurement of factor VII-activating protease (FSAP) activity and antigen levels in citrated plasma, their correlation to PCR testing, and utility for the detection of the Marburg I-polymorphism of FSAP.
    Stephan S; Schwarz H; Borchert A; Bussfeld D; Quak E; Simshaeuser-Knaub B; Teigelkamp S; Behrens F; Vitzthum F
    Clin Chem Lab Med; 2008; 46(8):1109-16. PubMed ID: 18605956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct chromogenic substrate immuno-capture activity assay for testing of factor VII-activating protease.
    Stephan S; Schwarz H; Haude-Barten A; Sidelmann JJ; Fischer B; Althaus H; Hahn M; Kappel A; Ehm M; Vitzthum F
    Clin Chem Lab Med; 2011 Jul; 49(7):1199-204. PubMed ID: 21663569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VII activating protease (FSAP): a novel protective factor in liver fibrosis.
    Martinez-Palacian A; Kanse SM; Weiskirchen R
    Proteomics Clin Appl; 2014 Jun; 8(5-6):438-46. PubMed ID: 24497464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme.
    Kannemeier C; Feussner A; Stöhr HA; Weisse J; Preissner KT; Römisch J
    Eur J Biochem; 2001 Jul; 268(13):3789-96. PubMed ID: 11432747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High negative charge-to-size ratio in polyphosphates and heparin regulates factor VII-activating protease.
    Muhl L; Galuska SP; Oörni K; Hernández-Ruiz L; Andrei-Selmer LC; Geyer R; Preissner KT; Ruiz FA; Kovanen PT; Kanse SM
    FEBS J; 2009 Sep; 276(17):4828-39. PubMed ID: 19664058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 is an inhibitor of factor VII-activating protease in patients with acute respiratory distress syndrome.
    Wygrecka M; Morty RE; Markart P; Kanse SM; Andreasen PA; Wind T; Guenther A; Preissner KT
    J Biol Chem; 2007 Jul; 282(30):21671-82. PubMed ID: 17540775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VII activating protease (FSAP) inhibits the outcome of ischemic stroke in mouse models.
    Kim JY; Manna D; Etscheid M; Leergaard TB; Kanse SM
    FASEB J; 2022 Oct; 36(10):e22564. PubMed ID: 36165219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.